A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels
Frédéric Tremblay(ChromaDex (United States)), Aron B. Jaffe(Biogen (United States)), Cristiana Giancarlo(Woman's Hospital), Songlei Liu(Harvard University), Erica M. Hildebrand(Woman's Hospital), C.M. Waters(Woman's Hospital), Angelo Lombardo(Vita-Salute San Raffaele University), Samantha J Linder(Massachusetts General Hospital), Taesun Eom(Woman's Hospital), Padma Malyala(Woman's Hospital), Sahar Abubucker(Washington University in St. Louis), Morgan L. Maeder(Editas Medicine (United States)), Vic E. Myer, Ricardo N. Ramírez(Woman's Hospital), Sarah B. Voytek(Woman's Hospital), Qiang Xiong(Woman's Hospital), José Simón Martínez-Castañeda(Woman's Hospital), M Morrison, Kenneth Kelly, Chih‐Wei Ko(Woman's Hospital), Scott Clarkson, Gabriel K El Sebae, Ari E. Friedland
Cited by 81
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
|Nature Biotechnology|2013|3.3k
RHO GTPASES: Biochemistry and Biology
|Annual Review of Cell and Developmental Biology|2005|3k
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
|Nature Biotechnology|2014|1.5k